Drug distribution in tumors: mechanisms, role in drug resistance, and methods for modification

Antonello Di Paolo1, Guido Bocci

  • 1Division of Pharmacology and Chemotherapy, Department of Internal Medicine, University of Pisa, Via Roma 55, 56126 Pisa, Italy. a.dipaolo@ao-pisa.toscana.it

Current Oncology Reports
|February 10, 2007
PubMed

Insights

Drug delivery to tumors is challenging due to poor drug distribution. Strategies like nanoparticles and vascular normalization aim to improve antineoplastic agent delivery and overcome chemotherapy resistance.

Area of Science:

  • Oncology
  • Pharmacology
  • Biomedical Engineering

Background:

  • Drug distribution within tumors is a major challenge in cancer chemotherapy.
  • Tumor microenvironment factors like poor vasculature, hypoxia, and high interstitial pressure impede drug penetration.
  • Cellular sequestration and extracellular matrix binding further limit drug efficacy and contribute to chemotherapy resistance.

Purpose of the Study:

  • To highlight the challenges in achieving effective antineoplastic agent distribution within solid tumors.
  • To discuss the factors contributing to inhomogeneous drug delivery and reduced tumor sensitivity.
  • To review emerging strategies aimed at overcoming drug resistance in cancer therapy.

Main Methods:

  • Review of existing literature on drug distribution challenges in solid tumors.
  • Analysis of tumor microenvironment characteristics affecting drug penetration.
  • Exploration of novel therapeutic strategies and formulations.

Main Results:

  • Inhomogeneous tumor vasculature, hypoxia, low pH, and high interstitial pressure create significant barriers to drug diffusion.
  • Physicochemical properties of drugs, cellular uptake, and binding to the extracellular matrix also limit distribution.
  • Emerging strategies include liposomal/nanoparticle formulations, bioreductive agents, and tumor vasculature normalization.

Conclusions:

  • Effective drug delivery to tumors is critical for successful cancer chemotherapy.
  • Addressing the complex tumor microenvironment and drug-specific factors is essential for improving treatment outcomes.
  • Ongoing research into advanced drug delivery systems and targeted therapies holds promise for overcoming chemotherapy resistance.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Drug Distribution: Tissue Binding01:21

Drug Distribution: Tissue Binding

Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
Drug Distribution: Overview01:11

Drug Distribution: Overview

Drug distribution within the body is a dynamic process involving the movement of a drug in two directions across various compartments: from the bloodstream into tissues (tissue uptake) and from tissues back into the bloodstream (tissue release or redistribution). This process is passive and primarily driven by two variables: the concentration gradient between the bloodstream and the extravascular tissues and the drug's ability to cross the cell membrane.
Initially, the free drug in the...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Tissue-Drug Binding: Localization of Drugs and its Significance01:24

Tissue-Drug Binding: Localization of Drugs and its Significance

Body tissues, comprising approximately 40% of the body weight, are crucial in drug distribution and localization. These tissues can serve as drug storage sites, competing with plasma binding sites for drug molecules.
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine the...
Factors Affecting Drug Distribution: Tissue Permeability01:30

Factors Affecting Drug Distribution: Tissue Permeability

The drug distribution process within the human body is a complex interplay of various physicochemical properties inherent to the drugs. These properties, including molecular size, ionization degree, partition coefficient, and stereochemical nature, significantly impact how drugs permeate biological membranes to reach their target tissues.
Small molecules with a molecular weight below 500 to 600 Daltons can easily pass through the capillary membrane, gaining access to different tissues. Larger...